Expected Moves

Borregaard ASA reports Q3 2026 earnings, aiming to recover from the severe -$1.27 EPS shock logged in Q2. Focus shifts to whether the Q2 hit was cyclical or structural.

Expected European Commission updates on green infrastructure and bio-economy grants, which directly impact Borregaard's long-term lignin valorization pipeline.

Release of Q4 2026 results alongside crucial full-year 2027 volume and pricing guidance for the specialty cellulose and biopolymers segments.

Management expected to provide a detailed update on capacity expansions following an elevated $138M CapEx run rate in recent quarters.

Q1 2027 financial results, marking the true test of Borregaard's ability to maintain pricing power against shifting macroeconomic conditions under a new fiscal year.